EURO-NanoTox-Letters is designed in such a way that different subsets of the content may be useful to upper-level undergraduate and postgraduate students, teaching and research professors in academic programs, scientists and research managers in industry, and to professionals with an active interest in nanotoxicologic research. EURO-NanoTox-Letters also includes review and background information useful to scientists entering the field of Nanotoxicology. Abstracts of the articles can be read without registration. Registration is necessary to read the full article.
The aim of EURO-NanoTox-Letters is to increase knowledge on interactions of nanoparticles in the physiological context by investigating adsorption, distribution, metabolism and elimination of nanoparticles in order to find out to which extent toxicity testing guidelines of drug products for nanoparticles can be used for the assessment of nanoparticle toxicity.
The following top-level category structure is proposed for EURO-NanoTox-Letters:
Permeation of nanoparticles across biological barriers
Interaction of nanoparticles with cells and effects of nanoparticles on cells
Changes of nanoparticles by interaction with physiological fluids
Absorption, distribution, metabolization and excretion of nanoparticles
Bio-persistance of nanoparticles
Interference with test systems
Methods for physico-chemical characterization of nanoparticles
The journal publishes original articles on all aspects of nanotoxicology; survey papers, which inform readers of the latest advances in nanotoxicology and short papers, which feature exciting research breakthroughs in the field are available resources. The journal includes in the Web-of-science database after few years depending on the success of publishing high impact papers regularly. We are looking forward to receiving high quality papers from all our colleagues to make this journal a leading publication in the field of nanotoxicology.
CrossCheck Plagiarism Screening System The editorial board is participating in a growing community of CrossCheck System's users in order to ensure that the content published is original and trustworthy. CrossCheck is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process.
Deputy/ Managing Editor Andreas Falk, BioNanoNet ForschungsgmbH, Austria
Editorial Board Eva Roblegg, Karl-Franzens Universität Graz, Austria Frank Sinner, JOANNEUM RESEARCH ForschungsgmbH, Graz, Austria Andreas Zimmer, Karl-Franzens Universität Graz, Austria
Editors De Gruyter Open
Advisory Board Alonso Maria José, Prof., University of Santiago de Compostela, ESP Couvreur Patrick, Prof., Paris-Sud University, Senior Member of the “Institut Universitaire de France”, FRA Duschl Albert, Prof. Dr., University of Salzburg, AUT Kreyling Wolfgang, Prof. Dr., Helmholtz-Institute Munich, GER Krol Silke, Dr., European Centre of Nanomedicine, Milano, ITA Lehr Claus-Michael, Prof. Dr., Saarland University, GER Piticescu Roxana Mioara, Dr., National R&D Institute for Nonferrous and Rare Metals, Pantelimon, ROM Rothen-Rutishauser Barbara, Prof. Dr., Chair Bio-Nanmoaterials, Adolphe Merkle Institute, Université de Fribourg, SUI Simkó Myrtill, Prof. Dr., Institute of Technology Assessment, Vienna, AUT Tran Lang C., Dr., Institute of Occupational Medicine, Edinburgh, GBR Vettukattil Joseph, B.Sc., MBBS, MD, DNB, MRCPCH, FRCP, Southampton University Hospitals, GBR